Background: Assessment of diabetes health takes into account metabolic, nonmetabolic, and self-care measures like diet, exercise, follow-up, and habits. On the other hand, the index of complications includes the macro- and microvascular complications of diabetes along with foot complications. The Blue Index (BI) is a composite assessment of both diabetic health-related parameters and systemic complications stemming from diabetes. The present study aimed to evaluate the diabetes control status of the patients as a single index.
Methods: A prospective, observational study included a total of 100 adult diabetic patients in whom diabetic health status (DHS) and Komplications Score (KS) were assessed for cardiovascular/macrovascular, microvascular, and foot complications. The BI was calculated as a composite ratio, and measures were obtained at baseline, after 3 months, and at 6 months. Data were statistically analyzed.
Results: Diabetic health status significantly increased at the 3rd month and the 6th month, respectively, compared to baseline (p = 0.000). KS significantly decreased at the 3rd month and the 6th month, respectively, compared to baseline measures (p = 0.000). The composite BI scores showed a steady increase of 9.62 at the 3rd month and 13.14 at the 6th month, respectively, compared to baseline. Assessing based on the duration of diabetes detection, the scores of DHS, KS, and BI showed similar changes. Assessing based on patients' gender, DHS was significantly higher in females at baseline compared to males, with gradual improvement in scores over time for both genders. Contrastingly, KS was significantly lower in males compared to females, with scores showing gradual decrement over the time frame, signifying improvement in complications. DHS was significantly correlated with the duration of diabetes detection (p = 0.001) and age (p = 0.01).
Conclusion: The BI is a simple tool that incorporates various parameters covering different aspects of diabetes care, including complications. It may be used not only by endocrinologists but also by all physicians as a tool to monitor and improve diabetic care.
{"title":"Blue Index as a Comprehensive, Patient-centered Assessment of Care in Diabetic Patients.","authors":"Rupak Chatterjee, Arindam Naskar, Shambo Samrat Samajdar, Shatavisa Mukherjee, Shashank Joshi, Partha Sarathi Karmakar","doi":"10.59556/japi.72.0688","DOIUrl":"10.59556/japi.72.0688","url":null,"abstract":"<p><strong>Background: </strong>Assessment of diabetes health takes into account metabolic, nonmetabolic, and self-care measures like diet, exercise, follow-up, and habits. On the other hand, the index of complications includes the macro- and microvascular complications of diabetes along with foot complications. The Blue Index (BI) is a composite assessment of both diabetic health-related parameters and systemic complications stemming from diabetes. The present study aimed to evaluate the diabetes control status of the patients as a single index.</p><p><strong>Methods: </strong>A prospective, observational study included a total of 100 adult diabetic patients in whom diabetic health status (DHS) and Komplications Score (KS) were assessed for cardiovascular/macrovascular, microvascular, and foot complications. The BI was calculated as a composite ratio, and measures were obtained at baseline, after 3 months, and at 6 months. Data were statistically analyzed.</p><p><strong>Results: </strong>Diabetic health status significantly increased at the 3rd month and the 6th month, respectively, compared to baseline (<i>p</i> = 0.000). KS significantly decreased at the 3rd month and the 6th month, respectively, compared to baseline measures (<i>p</i> = 0.000). The composite BI scores showed a steady increase of 9.62 at the 3rd month and 13.14 at the 6th month, respectively, compared to baseline. Assessing based on the duration of diabetes detection, the scores of DHS, KS, and BI showed similar changes. Assessing based on patients' gender, DHS was significantly higher in females at baseline compared to males, with gradual improvement in scores over time for both genders. Contrastingly, KS was significantly lower in males compared to females, with scores showing gradual decrement over the time frame, signifying improvement in complications. DHS was significantly correlated with the duration of diabetes detection (<i>p</i> = 0.001) and age (<i>p</i> = 0.01).</p><p><strong>Conclusion: </strong>The BI is a simple tool that incorporates various parameters covering different aspects of diabetes care, including complications. It may be used not only by endocrinologists but also by all physicians as a tool to monitor and improve diabetic care.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"e1-e5"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This article provides an overview of the diabetic kidney disease paradigm, explaining important aspects such as prognostic markers, clinical assessments, and therapeutic options. The importance of the term gluconephrotic syndrome (GlucoNS) is emphasized, highlighting its significant influence on clinical evaluations, research procedures, screening techniques, and patient care. This term encapsulates nephrotic syndrome (NS) within the diabetic milieu, shedding light on the intricate relationship between renal complications and diabetes. GlucoNS necessitates a refined approach, considering the unique challenges posed by diabetes in the context of NS. With this review, we want to highlight how important it is to assess diabetes in every case of NS and how important it is to assess albuminuria in every diabetic patient.
{"title":"Gluconephrotic Syndrome: A Comprehensive Review.","authors":"Sourabh Sharma, Sanjay Kalra","doi":"10.59556/japi.72.0687","DOIUrl":"https://doi.org/10.59556/japi.72.0687","url":null,"abstract":"<p><p>This article provides an overview of the diabetic kidney disease paradigm, explaining important aspects such as prognostic markers, clinical assessments, and therapeutic options. The importance of the term gluconephrotic syndrome (GlucoNS) is emphasized, highlighting its significant influence on clinical evaluations, research procedures, screening techniques, and patient care. This term encapsulates nephrotic syndrome (NS) within the diabetic milieu, shedding light on the intricate relationship between renal complications and diabetes. GlucoNS necessitates a refined approach, considering the unique challenges posed by diabetes in the context of NS. With this review, we want to highlight how important it is to assess diabetes in every case of NS and how important it is to assess albuminuria in every diabetic patient.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"58-62"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Osteonecrosis, characterized by ischemic bone injury leading to cell death and bone resorption, manifests in various anatomical sites due to multiple etiologies such as radiotherapy and medications. While certain sites like the femoral head and jaw have garnered attention, vertebral body osteonecrosis remains less explored and lacks a standardized classification system. This report presents a unique case of a 52-year-old woman undergoing chemotherapy for diffuse large B-cell lymphoma who developed multilevel vertebral body osteonecrosis, a rare occurrence in English medical literature. The patient presented with fever, abdominal pain, and lymphoid malignancy markers, initiating chemotherapy with the rituximab, cyclophosphamide, vincristine, and prednisolone (R-CVP) regimen. During treatment, she experienced breathing difficulties and back pain, prompting imaging studies revealing extensive osteonecrosis affecting multiple vertebrae and other skeletal sites. Various factors, including chemotherapy, human immunodeficiency virus (HIV) therapy, trauma, and others, contribute to vertebral body necrosis. While osteonecrosis in lymphoma patients is rare, chemotherapy-induced marrow necrosis can lead to bone involvement. Vertebral bodies, especially their anterior portions, are susceptible due to limited blood supply. The presence of an intravertebral vacuum cleft on radiographs is pathognomonic for osteonecrosis, while magnetic resonance imaging (MRI) reveals hypointense areas and fluid collections. This case underscores the complexity of diagnosing and managing multilevel vertebral body osteonecrosis, exacerbated by the lack of standardized protocols. The interplay between disease processes and treatment modalities complicates decision-making, emphasizing the need for further research to establish optimal diagnostic and treatment guidelines. In conclusion, this case sheds light on a rare manifestation of osteonecrosis in a lymphoma patient, highlighting the challenges in diagnosis and management. Further research is warranted to enhance understanding and improve outcomes for patients with this debilitating condition.
{"title":"Multilevel Vertebral Body Osteonecrosis in an Adult Patient: A Rare Case with Review of Literature.","authors":"Sonal Saran, Akash Rauniyar, Bhumireddy Vijaya Madhuri, Pooja Kundu","doi":"10.59556/japi.72.0640","DOIUrl":"10.59556/japi.72.0640","url":null,"abstract":"<p><p>Osteonecrosis, characterized by ischemic bone injury leading to cell death and bone resorption, manifests in various anatomical sites due to multiple etiologies such as radiotherapy and medications. While certain sites like the femoral head and jaw have garnered attention, vertebral body osteonecrosis remains less explored and lacks a standardized classification system. This report presents a unique case of a 52-year-old woman undergoing chemotherapy for diffuse large B-cell lymphoma who developed multilevel vertebral body osteonecrosis, a rare occurrence in English medical literature. The patient presented with fever, abdominal pain, and lymphoid malignancy markers, initiating chemotherapy with the rituximab, cyclophosphamide, vincristine, and prednisolone (R-CVP) regimen. During treatment, she experienced breathing difficulties and back pain, prompting imaging studies revealing extensive osteonecrosis affecting multiple vertebrae and other skeletal sites. Various factors, including chemotherapy, human immunodeficiency virus (HIV) therapy, trauma, and others, contribute to vertebral body necrosis. While osteonecrosis in lymphoma patients is rare, chemotherapy-induced marrow necrosis can lead to bone involvement. Vertebral bodies, especially their anterior portions, are susceptible due to limited blood supply. The presence of an intravertebral vacuum cleft on radiographs is pathognomonic for osteonecrosis, while magnetic resonance imaging (MRI) reveals hypointense areas and fluid collections. This case underscores the complexity of diagnosing and managing multilevel vertebral body osteonecrosis, exacerbated by the lack of standardized protocols. The interplay between disease processes and treatment modalities complicates decision-making, emphasizing the need for further research to establish optimal diagnostic and treatment guidelines. In conclusion, this case sheds light on a rare manifestation of osteonecrosis in a lymphoma patient, highlighting the challenges in diagnosis and management. Further research is warranted to enhance understanding and improve outcomes for patients with this debilitating condition.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"96-98"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Somarajan Anandan, Sajeesh S Rajendran, Jyothish P Kumar, Divine S Shajee
Majority of the eclampsia or preeclampsia occur between 20 weeks of gestation and within 48 hours postpartum. Postpartum eclampsia usually occurs on a background of preeclampsia. Late postpartum eclampsia (LPE) without preeclampsia is a rarity. LPE with posterior reversible encephalopathy syndrome (PRES) and mild hypertension is extremely rare. We report a case of LPE with PRES without preeclampsia, at a blood pressure of 140/90 mm Hg. Seizures occurring late postpartum period could be due to LPE and this can occur even with mild hypertension.
{"title":"Late Postpartum Eclampsia with \"Normal\" Blood Pressure.","authors":"Somarajan Anandan, Sajeesh S Rajendran, Jyothish P Kumar, Divine S Shajee","doi":"10.59556/japi.72.0661","DOIUrl":"10.59556/japi.72.0661","url":null,"abstract":"<p><p>Majority of the eclampsia or preeclampsia occur between 20 weeks of gestation and within 48 hours postpartum. Postpartum eclampsia usually occurs on a background of preeclampsia. Late postpartum eclampsia (LPE) without preeclampsia is a rarity. LPE with posterior reversible encephalopathy syndrome (PRES) and mild hypertension is extremely rare. We report a case of LPE with PRES without preeclampsia, at a blood pressure of 140/90 mm Hg. Seizures occurring late postpartum period could be due to LPE and this can occur even with mild hypertension.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"e37-e38"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Plasma cell invasion of the kidney in plasma cell dyscrasia is rare. We are reporting a case of plasma cell infiltration in the kidney presenting as rapidly progressing renal failure. The patient presented with generalized weakness, anemia, and advanced renal failure. The kidney biopsy revealed multifocal atypical CD138-positive plasma cell-rich interstitial inflammation and severe acute tubular injury. In the present situation of clinically unexplained renal failure with suspicion of plasma cell dyscrasia, a kidney biopsy proved to be key to the diagnosis. Hence, malignant plasma cell infiltration in the kidney could indicate underlying plasma cell dyscrasia and may serve as a future myeloma defining event (MDE).
{"title":"An Uncommon Finding of Plasma Cell Invasion of the Kidney in a Patient with Plasma Cell Dyscrasia: Should It be Considered a Myeloma Defining Event?","authors":"Prem Shankar Patel, Archana, Om Kumar","doi":"10.59556/japi.72.0708","DOIUrl":"10.59556/japi.72.0708","url":null,"abstract":"<p><p>Plasma cell invasion of the kidney in plasma cell dyscrasia is rare. We are reporting a case of plasma cell infiltration in the kidney presenting as rapidly progressing renal failure. The patient presented with generalized weakness, anemia, and advanced renal failure. The kidney biopsy revealed multifocal atypical CD138-positive plasma cell-rich interstitial inflammation and severe acute tubular injury. In the present situation of clinically unexplained renal failure with suspicion of plasma cell dyscrasia, a kidney biopsy proved to be key to the diagnosis. Hence, malignant plasma cell infiltration in the kidney could indicate underlying plasma cell dyscrasia and may serve as a future myeloma defining event (MDE).</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"e28-e30"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Raman Puri, Vimal Mehta, Manish Bansal, P Barton Duell, S S Iyengar, Sadanand Shetty, Ian Graham, J C Mohan, Upendra Kaul, Dayasagar Rao, Rajeev Agarwala, Gurpreet Singh Wander, Prakash Hazra, Soumitra Kumar, S K Wangnoo, Abdul Hamid Zargar, Banshi Saboo, Jamal Yusuf, Vinod M Vijan, Prem Aggarwal, Sarat Chandra, Ravi R Kasliwal, P C Manoria, M U Rabbani, Milan C Chag, D Prabhakar, Aziz Khan, Neil Bordoloi, Saravanan Palanippan, Kunal Mahajan, Akshay Pradhan, Dharmender Jain, A Murugnathan, Pradeep Kumar Dabla, Nagaraj Desai, Mangesh H Tiwaskar, Devaki R Nair, Charanjeet Singh, Jayant Panda, Vitull Gupta, Prashant Sahoo, Nathan D Wong
<p><p>Adverse cardiovascular (CV) events have declined in Western countries due at least in part to aggressive risk factor control, including dyslipidemia management. The American and European (Western) dyslipidemia treatment guidelines have contributed significantly to the reduction in atherosclerotic cardiovascular disease (ASCVD) incidence in the respective populations. However, their direct extrapolation to Indian patients does not seem appropriate for the reasons described below. In the US, mean low-density lipoprotein cholesterol (LDL-C) levels have markedly declined over the last 2 decades, correlating with a proportional reduction in CV events. Conversely, poor risk factor control and dyslipidemia management have led to increased CV and coronary artery disease (CAD) mortality rates in India. The population-attributable risk of dyslipidemia is about 50% for myocardial infarction, signifying its major role in CV events. In addition, the pattern of dyslipidemia in Indians differs considerably from that in Western populations, requiring unique strategies for lipid management in Indians and modified treatment targets. The Lipid Association of India (LAI) recognized the need for tailored LDL-C targets for Indians and recommended lower targets compared to Western guidelines. For individuals with established ASCVD or diabetes with additional risk factors, an LDL-C target of <50 mg/dL was recommended, with an optional target of ≤30 mg/dL for individuals at extremely high risk. There are several reasons that necessitate these lower targets. In Indian subjects, CAD develops 10 years earlier than in Western populations and is more malignant. Additionally, Indians experience higher CAD mortality despite having lower basal LDL-C levels, requiring greater LDL-C reduction to achieve a comparable CV event reduction. The Indian Council for Medical Research-India Diabetes study described a high prevalence of dyslipidemia among Indians, characterized by relatively lower LDL-C levels, higher triglyceride levels, and lower high-density lipoprotein cholesterol (HDL-C) levels compared to Western populations. About 30% of Indians have hypertriglyceridemia, aggravating ASCVD risk and complicating dyslipidemia management. The levels of atherogenic triglyceride-rich lipoproteins, including remnant lipoproteins, are increased in hypertriglyceridemia and are predictive of CV events. Hypertriglyceridemia is also associated with higher levels of small, dense LDL particles, which are more atherogenic, and higher levels of apolipoprotein B (Apo B), reflecting a higher burden of circulating atherogenic lipoprotein particles. A high prevalence of low HDL-C, which is often dysfunctional, and elevated lipoprotein(a) [Lp(a)] levels further contribute to the heightened atherogenicity and premature CAD in Indians. Considering the unique characteristics of atherogenic dyslipidemia in Indians, lower LDL-C, non-HDL-C, and Apo B goals compared to Western guidelines are required for
{"title":"Does Adopting Western Low-density Lipoprotein Cholesterol Targets Expose Indians to a Higher Risk of Cardiovascular Events? Expert Opinion From the Lipid Association of India.","authors":"Raman Puri, Vimal Mehta, Manish Bansal, P Barton Duell, S S Iyengar, Sadanand Shetty, Ian Graham, J C Mohan, Upendra Kaul, Dayasagar Rao, Rajeev Agarwala, Gurpreet Singh Wander, Prakash Hazra, Soumitra Kumar, S K Wangnoo, Abdul Hamid Zargar, Banshi Saboo, Jamal Yusuf, Vinod M Vijan, Prem Aggarwal, Sarat Chandra, Ravi R Kasliwal, P C Manoria, M U Rabbani, Milan C Chag, D Prabhakar, Aziz Khan, Neil Bordoloi, Saravanan Palanippan, Kunal Mahajan, Akshay Pradhan, Dharmender Jain, A Murugnathan, Pradeep Kumar Dabla, Nagaraj Desai, Mangesh H Tiwaskar, Devaki R Nair, Charanjeet Singh, Jayant Panda, Vitull Gupta, Prashant Sahoo, Nathan D Wong","doi":"10.59556/japi.72.0692","DOIUrl":"https://doi.org/10.59556/japi.72.0692","url":null,"abstract":"<p><p>Adverse cardiovascular (CV) events have declined in Western countries due at least in part to aggressive risk factor control, including dyslipidemia management. The American and European (Western) dyslipidemia treatment guidelines have contributed significantly to the reduction in atherosclerotic cardiovascular disease (ASCVD) incidence in the respective populations. However, their direct extrapolation to Indian patients does not seem appropriate for the reasons described below. In the US, mean low-density lipoprotein cholesterol (LDL-C) levels have markedly declined over the last 2 decades, correlating with a proportional reduction in CV events. Conversely, poor risk factor control and dyslipidemia management have led to increased CV and coronary artery disease (CAD) mortality rates in India. The population-attributable risk of dyslipidemia is about 50% for myocardial infarction, signifying its major role in CV events. In addition, the pattern of dyslipidemia in Indians differs considerably from that in Western populations, requiring unique strategies for lipid management in Indians and modified treatment targets. The Lipid Association of India (LAI) recognized the need for tailored LDL-C targets for Indians and recommended lower targets compared to Western guidelines. For individuals with established ASCVD or diabetes with additional risk factors, an LDL-C target of <50 mg/dL was recommended, with an optional target of ≤30 mg/dL for individuals at extremely high risk. There are several reasons that necessitate these lower targets. In Indian subjects, CAD develops 10 years earlier than in Western populations and is more malignant. Additionally, Indians experience higher CAD mortality despite having lower basal LDL-C levels, requiring greater LDL-C reduction to achieve a comparable CV event reduction. The Indian Council for Medical Research-India Diabetes study described a high prevalence of dyslipidemia among Indians, characterized by relatively lower LDL-C levels, higher triglyceride levels, and lower high-density lipoprotein cholesterol (HDL-C) levels compared to Western populations. About 30% of Indians have hypertriglyceridemia, aggravating ASCVD risk and complicating dyslipidemia management. The levels of atherogenic triglyceride-rich lipoproteins, including remnant lipoproteins, are increased in hypertriglyceridemia and are predictive of CV events. Hypertriglyceridemia is also associated with higher levels of small, dense LDL particles, which are more atherogenic, and higher levels of apolipoprotein B (Apo B), reflecting a higher burden of circulating atherogenic lipoprotein particles. A high prevalence of low HDL-C, which is often dysfunctional, and elevated lipoprotein(a) [Lp(a)] levels further contribute to the heightened atherogenicity and premature CAD in Indians. Considering the unique characteristics of atherogenic dyslipidemia in Indians, lower LDL-C, non-HDL-C, and Apo B goals compared to Western guidelines are required for ","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"71-76"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Upinderjeet Singh, Rekha Gupta, Ashok K Attri, Nitin Gupta, Uma Handa
Aim: To evaluate thyroid nodules with sonoelastography and magnetic resonance imaging (MRI).
Materials and methods: The study included 28 patients with 40 thyroid nodules. Clearance was obtained from the institute's ethical clearance committee. Patients with pure cystic nodules or nodules with eggshell calcification, diffuse thyroid pathology (such as Graves' disease, Hashimoto's thyroiditis, De Quervain thyroiditis, and Riedel's thyroiditis), inaccessible nodules via fine needle aspiration cytology (FNAC), or patients with a history of thyroid gland surgery were excluded from the study. Strain elastography was performed on a Phillips iU22 machine, producing qualitative color-coded strain maps (graded using the Rago 5-point system) and semiquantitative strain ratios. MRI was performed on a Phillips ACHIEVA 1.5T magnet with a head and neck coil.
Results: Rago scores statistically correlated (χ2 = 18.052, p < 0.001) with malignant nodules, and using the receiver operating characteristic (ROC) curve, the area under the ROC curve (AUROC) for the mean strain ratio predicting malignant outcomes was 0.88 [95% confidence interval (CI): 0.767-0.992], which was also statistically significant (p < 0.001). A cutoff of mean strain ratio ≥2.48 predicted malignant outcomes with 100% specificity. T2 signal intensity ratio (SIR) and apparent diffusion coefficient (ADC) values were not statistically significant in predicting malignant outcomes. Kinetic curves were statistically significant for Rago scores (χ2 = 11.356, p = 0.045); however, no significant difference was found in predicting malignant outcomes.
Conclusion and clinical significance: We concluded that sonoelastography, along with grayscale ultrasound, is a useful noninvasive technique for predicting histological outcomes. However, MRI should largely be reserved as a problem-solving tool rather than a standalone imaging modality. The kinetic curves show some degree of overlap between histologically distinct diseases, and thus large-scale multicenter trials are needed for further standardization.
{"title":"Utility of Sonoelastography and Magnetic Resonance Imaging in Characterization of Thyroid Nodules.","authors":"Upinderjeet Singh, Rekha Gupta, Ashok K Attri, Nitin Gupta, Uma Handa","doi":"10.59556/japi.72.0709","DOIUrl":"https://doi.org/10.59556/japi.72.0709","url":null,"abstract":"<p><strong>Aim: </strong>To evaluate thyroid nodules with sonoelastography and magnetic resonance imaging (MRI).</p><p><strong>Materials and methods: </strong>The study included 28 patients with 40 thyroid nodules. Clearance was obtained from the institute's ethical clearance committee. Patients with pure cystic nodules or nodules with eggshell calcification, diffuse thyroid pathology (such as Graves' disease, Hashimoto's thyroiditis, De Quervain thyroiditis, and Riedel's thyroiditis), inaccessible nodules <i>via</i> fine needle aspiration cytology (FNAC), or patients with a history of thyroid gland surgery were excluded from the study. Strain elastography was performed on a Phillips iU22 machine, producing qualitative color-coded strain maps (graded using the Rago 5-point system) and semiquantitative strain ratios. MRI was performed on a Phillips ACHIEVA 1.5T magnet with a head and neck coil.</p><p><strong>Results: </strong>Rago scores statistically correlated (<i>χ</i><sup>2</sup> = 18.052, <i>p</i> < 0.001) with malignant nodules, and using the receiver operating characteristic (ROC) curve, the area under the ROC curve (AUROC) for the mean strain ratio predicting malignant outcomes was 0.88 [95% confidence interval (CI): 0.767-0.992], which was also statistically significant (<i>p</i> < 0.001). A cutoff of mean strain ratio ≥2.48 predicted malignant outcomes with 100% specificity. T2 signal intensity ratio (SIR) and apparent diffusion coefficient (ADC) values were not statistically significant in predicting malignant outcomes. Kinetic curves were statistically significant for Rago scores (<i>χ</i><sup>2</sup> = 11.356, <i>p</i> = 0.045); however, no significant difference was found in predicting malignant outcomes.</p><p><strong>Conclusion and clinical significance: </strong>We concluded that sonoelastography, along with grayscale ultrasound, is a useful noninvasive technique for predicting histological outcomes. However, MRI should largely be reserved as a problem-solving tool rather than a standalone imaging modality. The kinetic curves show some degree of overlap between histologically distinct diseases, and thus large-scale multicenter trials are needed for further standardization.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"e13-e17"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Many among us and some students have a personal idiosyncrasy to remember eponyms in clinical medicine and other subjects such as signs, tests, phenomena, and rules named after a person who originally described them. However, it is not always necessary as long as one knows what they mean. Józef Brudziński's name is given to four eponymous medical signs associated with reflexes observed in meningeal irritation along with Kernig's sign.
{"title":"Brudziński and His Signs.","authors":"Jayant Pai-Dhungat, Aparna Verma","doi":"10.59556/japi.72.0697","DOIUrl":"https://doi.org/10.59556/japi.72.0697","url":null,"abstract":"<p><p>Many among us and some students have a personal idiosyncrasy to remember eponyms in clinical medicine and other subjects such as signs, tests, phenomena, and rules named after a person who originally described them. However, it is not always necessary as long as one knows what they mean. Józef Brudziński's name is given to four eponymous medical signs associated with reflexes observed in meningeal irritation along with Kernig's sign.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"108"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aryan Rafieezadeh, Kartik Prabhakaran, Amirhossein Sadeghian, Anna Mary Jose, Bardiya Zangbar
Traumatic brain injury (TBI) causes significant mortality and morbidity across regions, imposing a substantial socioeconomic burden on societies. A major complication that can arise is uncontrolled intracranial pressure (ICP). Several strategies exist for reducing ICP in TBI patients, including head elevation, mannitol administration, and hyperventilation. Decompressive craniectomy (DC) is a therapeutic approach employed to lower ICP. This technique offers immediate and permanent relief from elevated ICP, although there are ongoing debates regarding its beneficial use and appropriate indications for patients with increased ICP. The objective of this review was to assess variations in surgical technique, timing of the procedure, and patient characteristics associated with DC. Through the evaluation of clinical and radiologic data concerning DC in patients with elevated ICP, it was revealed that while DC provides numerous benefits, it also carries a significant risk of mortality and morbidity. Furthermore, we observed that factors such as age, initial Glasgow Coma Scale (GCS) score, pupil response, and the time interval between injury and DC can serve as predictors for the procedure's outcomes. Based on our findings, we recommend conducting further trials to shed light on the use of DC in TBI patients.
创伤性脑损伤(TBI)在各个地区都会造成严重的死亡率和发病率,给社会造成巨大的社会经济负担。可能出现的一个主要并发症是颅内压(ICP)失控。有几种策略可以降低创伤性脑损伤患者的 ICP,包括抬高头部、给予甘露醇和过度通气。减压开颅术(DC)是一种用于降低 ICP 的治疗方法。该技术可立即、永久地缓解 ICP 升高,但关于其对 ICP 增高患者的有益用途和适当适应症仍存在争议。本综述旨在评估与 DC 相关的手术技术、手术时机和患者特征的变化。通过评估有关 ICP 增高患者 DC 的临床和放射学数据,我们发现,虽然 DC 有诸多益处,但也有很大的死亡率和发病率风险。此外,我们还观察到,年龄、初始格拉斯哥昏迷量表(GCS)评分、瞳孔反应以及损伤与 DC 之间的时间间隔等因素可作为手术结果的预测因素。基于我们的研究结果,我们建议开展进一步的试验,以阐明如何在创伤性脑损伤患者中使用 DC。
{"title":"Optimizing Traumatic Brain Injury Recovery: Exploring the Advantages and Results of Decompressive Craniectomy.","authors":"Aryan Rafieezadeh, Kartik Prabhakaran, Amirhossein Sadeghian, Anna Mary Jose, Bardiya Zangbar","doi":"10.59556/japi.72.0705","DOIUrl":"https://doi.org/10.59556/japi.72.0705","url":null,"abstract":"<p><p>Traumatic brain injury (TBI) causes significant mortality and morbidity across regions, imposing a substantial socioeconomic burden on societies. A major complication that can arise is uncontrolled intracranial pressure (ICP). Several strategies exist for reducing ICP in TBI patients, including head elevation, mannitol administration, and hyperventilation. Decompressive craniectomy (DC) is a therapeutic approach employed to lower ICP. This technique offers immediate and permanent relief from elevated ICP, although there are ongoing debates regarding its beneficial use and appropriate indications for patients with increased ICP. The objective of this review was to assess variations in surgical technique, timing of the procedure, and patient characteristics associated with DC. Through the evaluation of clinical and radiologic data concerning DC in patients with elevated ICP, it was revealed that while DC provides numerous benefits, it also carries a significant risk of mortality and morbidity. Furthermore, we observed that factors such as age, initial Glasgow Coma Scale (GCS) score, pupil response, and the time interval between injury and DC can serve as predictors for the procedure's outcomes. Based on our findings, we recommend conducting further trials to shed light on the use of DC in TBI patients.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"e18-e22"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We present a case of Streptococcus iniae causing leptomeningitis, pyocephalus, and subdural empyema in an elderly male from India. There have been only a handful of cases of S. iniae infection reported worldwide, and none of them have been from India. In this case, an elderly diabetic patient presenting with backache, headache, and fever with severe neurological worsening was diagnosed with severe invasive S. iniae infection. He had hydrocephalus that needed ventriculoperitoneal shunting. The patient was treated with a prolonged course of intravenous ampicillin and vancomycin.
{"title":"A Case of <i>Streptococcus iniae</i> Pyocephalus, Subdural Empyema, and Diffuse Leptomeningitis in an Elderly Male: A Case Report.","authors":"Abdeali Ginwala, Ajit Tambolkar, Sanjay Pujari","doi":"10.59556/japi.72.0689","DOIUrl":"10.59556/japi.72.0689","url":null,"abstract":"<p><p>We present a case of Streptococcus iniae causing leptomeningitis, pyocephalus, and subdural empyema in an elderly male from India. There have been only a handful of cases of S. iniae infection reported worldwide, and none of them have been from India. In this case, an elderly diabetic patient presenting with backache, headache, and fever with severe neurological worsening was diagnosed with severe invasive S. iniae infection. He had hydrocephalus that needed ventriculoperitoneal shunting. The patient was treated with a prolonged course of intravenous ampicillin and vancomycin.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 10","pages":"e34-e36"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}